Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Non-Rx Zocor Will Be Available In UK Without Cholesterol Screen Requirement

This article was originally published in The Tan Sheet

Executive Summary

Customers who present at UK pharmacies to purchase McNeil Europe's Zocor Heart-Pro (simvastatin 10 mg) without a prescription will need to disclose risk factors such as age and family history of heart disease, but not necessarily their cholesterol level, under a marketing plan cleared by the UK health agency
Advertisement

Related Content

Primary Prevention Of Heart Risk Factors Trumps Secondary Prevention – BMJ
MHRA Looks To Triptans, Anti-Hypertensives As Next Switch Categories
UK Pharmacy Zocor Faces “Major Challenges” Communicating Risk Factors
British Pharmacy-Only Statin Paradigm Immaterial To U.S. Switch – NEJM
FDA Mevacor OTC Switch Answer: Signs Point To “Not Approvable”
UK Zocor Experience Inadequate To Sway FDA Panel On Mevacor
Pravachol OTC Deal Reached Between Bayer, Bristol
Zocor Ad Targets Diabetics With Reference To Heart Protection Study
Zocor Brand For Pharmacy Access Drug May Create Confusion – Galpharm
Simvastatin, Xenical, Nasacort Switch Decisions Imminent In New Zealand

Topics

Advertisement
UsernamePublicRestriction

Register

PS096834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel